Show simple item record

dc.contributor.authorSherlock, Mark
dc.contributor.authorToogood, Andy A
dc.contributor.authorSteeds, Richard
dc.date.accessioned2012-11-30T16:30:24Z
dc.date.available2012-11-30T16:30:24Z
dc.date.issued2009-04
dc.identifier.citationDopamine agonist therapy for hyperprolactinaemia and cardiac valve dysfunction; a lot done but much more to do. 2009, 95 (7):522-3 Hearten_GB
dc.identifier.issn1468-201X
dc.identifier.pmid19174419
dc.identifier.doi10.1136/hrt.2008.163345
dc.identifier.urihttp://hdl.handle.net/10147/254115
dc.language.isoenen
dc.publisherHeart (British Cardiac Society)en_GB
dc.rightsArchived with thanks to Heart (British Cardiac Society)en_GB
dc.subject.meshDopamine Agonists
dc.subject.meshEchocardiography
dc.subject.meshErgolines
dc.subject.meshHeart Valve Diseases
dc.subject.meshHeart Valves
dc.subject.meshHumans
dc.subject.meshHyperprolactinemia
dc.subject.meshParkinson Disease
dc.subject.meshPergolide
dc.subject.meshTricuspid Valve Insufficiency
dc.titleDopamine agonist therapy for hyperprolactinaemia and cardiac valve dysfunction; a lot done but much more to do.en_GB
dc.typeArticleen
dc.identifier.journalHeart (British Cardiac Society)en_GB
dc.description.provinceLeinsteren


This item appears in the following Collection(s)

Show simple item record